pubmed-article:16984232 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0001675 | lld:lifeskim |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0037663 | lld:lifeskim |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0085732 | lld:lifeskim |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0441994 | lld:lifeskim |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
pubmed-article:16984232 | lifeskim:mentions | umls-concept:C0597152 | lld:lifeskim |
pubmed-article:16984232 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:16984232 | pubmed:dateCreated | 2006-9-20 | lld:pubmed |
pubmed-article:16984232 | pubmed:abstractText | The aim of the study was to characterize lipid oxidation at exercise in adults with growth hormone deficiency (GHD) and to evaluate the effect of 6 and 12 months of GH replacement therapy on substrate carbohydrate (CHO) and lipid utilization at exercise. | lld:pubmed |
pubmed-article:16984232 | pubmed:language | eng | lld:pubmed |
pubmed-article:16984232 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16984232 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16984232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16984232 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16984232 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16984232 | pubmed:month | Oct | lld:pubmed |
pubmed-article:16984232 | pubmed:issn | 0300-0664 | lld:pubmed |
pubmed-article:16984232 | pubmed:author | pubmed-author:MercierJJ | lld:pubmed |
pubmed-article:16984232 | pubmed:author | pubmed-author:BrandonMM | lld:pubmed |
pubmed-article:16984232 | pubmed:author | pubmed-author:BrunJ FJF | lld:pubmed |
pubmed-article:16984232 | pubmed:author | pubmed-author:FédouCC | lld:pubmed |
pubmed-article:16984232 | pubmed:author | pubmed-author:AloulouII | lld:pubmed |
pubmed-article:16984232 | pubmed:author | pubmed-author:RazimbaudAA | lld:pubmed |
pubmed-article:16984232 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16984232 | pubmed:volume | 65 | lld:pubmed |
pubmed-article:16984232 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16984232 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16984232 | pubmed:pagination | 423-8 | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:meshHeading | pubmed-meshheading:16984232... | lld:pubmed |
pubmed-article:16984232 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16984232 | pubmed:articleTitle | Lower ability to oxidize lipids in adult patients with growth hormone (GH) deficiency: reversal under GH treatment. | lld:pubmed |
pubmed-article:16984232 | pubmed:affiliation | Service Central de Physiologie Clinique, Centre d'Exploration et de Réadaptation des Anomalies du Métabolisme Musculaire, CHU Montpellier, France. fredbrandou@yahoo.fr | lld:pubmed |
pubmed-article:16984232 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16984232 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16984232 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16984232 | lld:pubmed |